Anti-diabetic effect of ginsenoside Re in ob/ob mice

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1740, Issue 3, 2005, Pages 319-325

  Xie, Jing Tian ^a,b   Mehendale, Sangeeta R ^a,b   Li, Xinmin ^b   Quigg, Richard ^b   Wang, Xiaoyu ^b   Wang, Chong Zhi ^a,b   Ji, An Wu ^a,b   Aung, Han H ^a,b   Rue, Paul A ^b   Bell, Graeme I ^b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Diabetes; Ginsenoside Re; Insulin; Intraperitoneal glucose tolerance test; Microarray; ob ob mouse

Indexed keywords

GINSENOSIDE RE; GLUCOSE; INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; MOUSE; MUSCLE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE MICROARRAY; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GINSENOSIDES; INSULIN; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TIME FACTORS;

EID: 20444417081     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.10.010     Document Type: Article

References (22)

1. National Institutes of Diabetes and Digestive and Kidney Diseases Diabetes Statistics 1995
2. Diabetes Vital Statistics 1996 American Diabetes Association Alexandria, VA
3. Diabetes Research Working Group Conquering Diabetes-A Strategic Plan for the 21st Century 1999
4. Q.Z. Liu, D.J. Pettitt, R.L. Hanson, M.A. Charles, R. Klein, P.H. Bennett, and W.C. Knowler Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses Diabetologia 36 1993 428 432
5. R. Klein, B.E. Klein, S.E. Moss, and K.J. Cruickshanks Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy Arch. Intern. Med. 154 1994 2169 2178
6. C. Abraira, J.A. Colwell, F.Q. Nuttall, C.T. Sawin, N.J. Nagel, J.P. Comstock, N.V. Emanuele, S.R. Levin, W. Henderson, and H.S. Lee Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans affairs cooperative study in type II diabetes Diabetes Care 18 1995 1113 1123
7. Y. Ohkubo, H. Kishikawa, E. Araki, T. Miyata, S. Isami, S. Motoyoshi, Y. Kojima, N. Furuyoshi, and M. Shichiri Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study Diabetes Res. Clin. Pract. 28 1995 103 117
8. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
9. R.A. DeFronzo Pharmacologic therapy for type 2 diabetes mellitus Ann. Intern. Med. 131 1999 281 303
10. A.S. Attele, Y.P. Zhou, J.T. Xie, J.A. Wu, L. Zhang, L. Dey, W. Pugh, P.A. Rue, K.S. Polonsky, and C.S. Yuan Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component Diabetes 51 2002 1851 1858
11. S.M. Genuth, R.J. Przybylski, and D.M. Rosenberg Insulin resistance in genetically obese, hyperglycemic mice Endocrinology 88 1971 1230 1238
12. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
13. K.C. Huang The Pharmacology of Chinese Herbs 1999 CRC Press Boca Raton, FL
14. L. Dey, A.S. Attele, and C.S. Yuan Alternative therapies for type 2 diabetes Altern. Med. Rev. 7 2002 45 58
15. A.S. Attele, J.A. Wu, and C.S. Yuan Ginseng pharmacology: multiple constituents and multiple actions Biochem. Pharmacol. 58 1999 1685 1693
16. G.M. Reaven Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured? Am. J. Med. 74 1983 3 17
17. R.A. DeFronzo, and E. Ferrannini Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease Diabetes Care 14 1991 173 194
18. J.E. Friedman, G.L. Dohm, N. Leggett-Frazier, C.W. Elton, E.B. Tapscott, W.P. Pories, and J.F. Caro Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4 J. Clin. Invest. 89 1992 701 705
19. I. Kimura, N. Nakashima, Y. Sugihara, C. Fu-jun, and M. Kimura The antihyperglycaemic blend effect of traditional Chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice Phytother. Res. 13 1999 484 488
20. V. Vuksan, J.L. Sievenpiper, V.Y. Koo, T. Francis, U. Beljan-Zdravkovic, Z. Xu, and E. Vidgen American ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus Arch. Intern. Med. 160 2000 1009 1013
21. S.E. Chen, R.J. Sawchuk, and E.J. Staba American ginseng: III. Pharmacokinetics of ginsenosides in the rabbit Eur. J. Drug Metab. Pharmacokinet. 5 1980 161 168
22. J.M. Ntambi, and M. Miyazaki Recent insights into stearoyl-CoA desaturase-1 Curr. Opin. Lipidol. 14 2003 255 261